緑内障手術装置の世界市場規模：製品タイプ別、手術タイプ別、エンドユーザー別、地域範囲別および予測

緑内障手術装置の市場規模と予測

緑内障手術装置市場規模は、2024年に11億3,386万米ドルと評価され、2026～2032年にかけて28.20%のCAGRで成長し、2032年には70億606万米ドルに達すると予測されています。

• 緑内障手術装置は、世界的に不可逆的失明の主要原因である緑内障の外科的管理に使用される特殊装置です。
• これらの装置は、トラベクレクトミー、チューブシャント手術、低侵襲緑内障手術（MIGS）など、さまざまな手術に利用されています。
• これらの装置の応用は、緑内障と診断された患者の眼圧（IOP）を下げ、視力を維持するために不可欠です。
• 緑内障治療における革新的かつ効果的なソリューションに対する需要は、人口の高齢化と緑内障の有病率の上昇によって高まっています。
• この動向は、緑内障手術の有効性と安全性を高める技術と手術技術の著しい進歩につながっています。
• その結果、現在進行中の研究開発努力に支えられ、先進国市場と市場の両方において、これらの装置の採用が顕著に増加すると予想されます。

緑内障手術装置の世界市場力学

世界の緑内障手術装置市場を形成している主要市場力学は以下の通りです。

主要市場促進要因

• 緑内障の有病率：緑内障の有病率は世界的に高く、数百万人がこの慢性疾患に罹患していると報告されています。このような患者数の増加が、緑内障手術装置の需要を大きく押し上げると予測されています。システマティックレビューとメタアナリシスによると、世界の緑内障患者数は2020年には7,600万人と推定され、2040年には1億1,180万人に増加すると予測されています。
• 人口の高齢化：高齢化社会の進行は、緑内障を含む加齢に関連した眼疾患の発生率の上昇につながります。高齢者の増加は、効果的な外科的介入に対する需要に貢献すると予想されます。
• 技術の進歩：緑内障手術装置のセグメントでは、安全性と有効性を高める技術の進歩が進んでいます。これらの技術革新は、患者により良い治療選択肢を提供することで市場の成長を刺激すると予測されます。
• ヘルスケア支出：先進地域を中心にヘルスケア支出の増加が指摘されており、先進医療装置への投資が促進される可能性が高いです。この動向は、病院やクリニックが手術能力を向上させようとしていることから、緑内障手術装置の採用を後押しすると予想されます。

主要課題

• 高額な装置費用：緑内障手術装置に関連する高コストが大きな抑制要因として指摘されています。特に新興市場では、このような高額な費用が一部のヘルスケア提供者のアクセスを制限することが予想されます。
• 償還の問題：多くのヘルスケアシステムが償還の問題に直面しており、そこでは緑内障手術に対する保険が一貫して提供されていないです。病院は確実な償還がなければ先端技術への投資をためらう可能性があるため、こうした課題は緑内障手術装置市場の成長を阻害すると予想されます。
• 熟練した専門家の不足：先進的緑内障手術技術の訓練を受けた熟練した専門家の不足が指摘されています。この不足は、臨床現場における革新的な緑内障手術装置の効果的な導入と利用を抑制すると予測されます。
• 患者の意識：緑内障やその治療法に関する患者の意識は、特に開発途上地域では限定的であることが多いです。このような認識不足は、適時に治療を受けようとしない可能性があるため、緑内障手術装置の需要を妨げると推定されます。

主要動向

• 低侵襲手術の需要：低侵襲手術に対する高い需要が、患者とヘルスケア提供者の双方で観察されています。この動向により、より低侵襲な手技のために特別に設計された緑内障手術装置の採用が増加し、回復時間の短縮が促進されると予想されます。
• デジタル技術の統合：人工知能や遠隔医療などのデジタル技術の統合が緑内障管理セグメントで進んでいることが報告されています。これらの進歩により、診断精度や手術計画の向上が期待され、関連手術装置市場の牽引役となっています。
• 個別化医療への注目：緑内障治療では個別化医療への注目が高まっています。この動向は、個々の患者のニーズに対応するテーラーメイドの外科的介入や装置の開発を促進すると予測されています。
• メーカーとヘルスケアプロバイダのコラボレーション：緑内障手術装置メーカーとヘルスケアプロバイダ間の協力関係の高まりが注目されています。これにより、知識やリソースの共有が促進され、革新的な製品の開発や手術成績の向上が期待されます。

目次

第1章 世界の緑内障手術装置市場の導入

• 市場の導入
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 緑内障手術装置の世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 緑内障手術装置の世界市場：製品別

• 概要
• 緑内障ドレナージ装置
• 緑内障レーザー装置
• インプラントとステント

第6章 緑内障手術装置の世界市場：手術タイプ別

• 概要
• 低侵襲緑内障手術
• 従来型緑内障手術

第7章 緑内障手術装置の世界市場：エンドユーザー別

• 概要
• 眼科病院と眼科クリニック
• 外来手術センター
• 外来手術センター

第8章 緑内障手術装置の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋
• その他
  • ラテンアメリカ
  • 中東・アフリカ

第9章 世界の緑内障手術装置市場の競合情勢

• 概要
• 各社の市場ランキング
• 主要開発戦略

第10章 企業プロファイル

• Carl Zeiss Meditec AG
• Abbott Laboratories
• Iridex Corporation
• Alcon, Inc.
• Glaukos Corporation
• ASICO
• Katalyst Surgical
• Ziemer Ophthalmic Systems AG
• Lumenis Ltd.

第11章 付録

• 関連調査"

Glaucoma Surgery Devices Market Size And Forecast

Glaucoma Surgery Devices Market size was valued at USD 1133.86 Million in 2024 and is projected to reach USD 7006.06 Million by 2032, growing at a CAGR of 28.20% from 2026 to 2032.

• Glaucoma surgery devices are specialized instruments used in the surgical management of glaucoma, a leading cause of irreversible blindness worldwide.
• These devices are utilized in various procedures, including trabeculectomy, tube shunt surgery, and minimally invasive glaucoma surgery (MIGS).
• The application of these devices is essential in lowering intraocular pressure (IOP) and preserving vision in patients diagnosed with glaucoma.
• A growing demand for innovative and effective solutions in glaucoma treatment is being witnessed, driven by an aging population and a rising prevalence of the disease.
• This trend has led to significant advancements in technology and surgical techniques, enhancing the effectiveness and safety of glaucoma surgeries.
• Consequently, a notable increase in the adoption of these devices is anticipated in both developed and emerging markets, supported by ongoing research and development efforts.

Global Glaucoma Surgery Devices Market Dynamics

The key market dynamics that are shaping the global glaucoma surgery devices market include:

Key Market Drivers:

• Prevalence of Glaucoma: A high prevalence of glaucoma is being reported globally, with millions of individuals affected by this chronic condition. It is anticipated that this growing patient population will drive the demand for glaucoma surgery devices significantly. According to a systematic review and meta-analysis, the number of people with glaucoma worldwide was estimated to be 76 million in 2020, with projections suggesting this number will increase to 111.8 million by 2040.
• Aging Population: A growing aging population is being observed, leading to an increased incidence of age-related eye diseases, including glaucoma. The rising number of elderly individuals is expected to contribute to the demand for effective surgical interventions.
• Advancements In Technology: Increasing advancements in technology are being made in the field of glaucoma surgery devices, enhancing their safety and efficacy. These innovations are projected to stimulate market growth by providing better treatment options for patients.
• Healthcare Expenditure: A rising healthcare expenditure is being noted, particularly in developed regions, which is likely to facilitate investment in advanced medical devices. This trend is expected to support the adoption of glaucoma surgery devices as hospitals and clinics seek to upgrade their surgical capabilities.

Key Challenges:

• High Costs of Devices: The high costs associated with glaucoma surgery devices are being identified as a significant restraint. It is anticipated that these elevated expenses will limit access for some healthcare providers, especially in emerging markets.
• Reimbursement Issues: Reimbursement issues are being faced by many healthcare systems, where coverage for glaucoma surgeries is not consistently provided. It is expected that these challenges will impede the growth of the glaucoma surgery devices market as hospitals may hesitate to invest in advanced technologies without assured reimbursement.
• Lack of Skilled Professionals: A lack of skilled professionals trained in advanced glaucoma surgical techniques is being noted. This shortage is projected to restrain the effective implementation and utilization of innovative glaucoma surgery devices in clinical settings.
• Patient Awareness: Patient awareness regarding glaucoma and its surgical treatment options is often limited, particularly in developing regions. It is estimated that this lack of awareness will hamper the demand for glaucoma surgery devices, as individuals may not seek timely treatment.

Key Trends:

• Demand for Minimally Invasive Procedures: A high demand for minimally invasive procedures is being observed among both patients and healthcare providers. It is anticipated that this trend will lead to the increased adoption of glaucoma surgery devices specifically designed for less invasive techniques, promoting quicker recovery times.
• Integration of Digital Technologies: Growing integration of digital technologies, such as artificial intelligence and telemedicine, is being reported in the glaucoma management sector. These advancements are expected to enhance the diagnostic accuracy and surgical planning, thereby driving the market for associated surgical devices.
• Focus on Personalized Medicine: An increasing focus on personalized medicine is being recognized within the glaucoma treatment landscape. It is projected that this trend will encourage the development of tailored surgical interventions and devices that cater to individual patient needs.
• Collaboration Between Manufacturers and Healthcare Providers: Rising collaboration between manufacturers of glaucoma surgery devices and healthcare providers is being noted. It is likely to facilitate the sharing of knowledge and resources, resulting in the development of innovative products and improved surgical outcomes.

Global Glaucoma Surgery Devices Market Regional Analysis

Here is a more detailed regional analysis of the global glaucoma surgery devices market:

North America:

• North America is expected to dominate the glaucoma surgery devices market due to advanced healthcare infrastructure and high prevalence rates of glaucoma.
• According to the National Eye Institute, more than 3 million Americans had glaucoma in 2020, a number projected to reach 4.2 million by 2030.
• The United States is anticipated to hold the largest share, driven by the presence of key market players and a strong emphasis on research and development.
• Increasing healthcare expenditures and a growing elderly population are projected to further contribute to market growth in the region.
• In Canada, a rising awareness of eye health is being observed, leading to more frequent screenings and diagnoses of glaucoma.
• It is estimated that advancements in minimally invasive surgical techniques will enhance the adoption of glaucoma surgery devices.
• The presence of a robust healthcare system is likely to support the ongoing growth of this market segment.

Europe:

• Europe is anticipated to experience significant growth in the glaucoma surgery devices market, attributed to the increasing aging population and high incidence of glaucoma across the region.
• According to Eurostat, the percentage of people aged 65 and over in the EU-27 is projected to increase from 20.3% in 2019 to 29.4% by 2050. The European Glaucoma Society reports that the prevalence of glaucoma in Europe is approximately 2.93% in people over 40, rising to 5.1% in those over 75.
• Countries such as Germany and France are projected to lead the market, driven by a combination of advanced healthcare facilities and government initiatives aimed at improving eye care services.
• Rising investments in innovative surgical technologies are expected to foster market expansion in these nations.
• The United Kingdom is also likely to contribute to regional growth through the implementation of public health campaigns focusing on glaucoma awareness.
• Enhanced access to advanced surgical procedures is projected to boost the adoption of glaucoma surgery devices.
• Additionally, collaborations between healthcare providers and device manufacturers are anticipated to facilitate the development of new and effective treatment options.

Global Glaucoma Surgery Devices Market: Segmentation Analysis

The Global Glaucoma Surgery Devices Market is Segmented on the basis of Product, Surgery Type, End-Users, And Geography.

Glaucoma Surgery Devices Market, By Product

• Glaucoma Drainage Devices
• Glaucoma Laser Devices
• Implants And Stents

Based on Product, the market is bifurcated into Glaucoma Drainage Devices, Glaucoma Laser Devices, and Implants And Stents. Glaucoma drainage devices are expected to hold the largest share of the glaucoma surgery devices market due to their effectiveness in managing intraocular pressure (IOP) in patients with refractory glaucoma. Increasing prevalence rates of glaucoma and the growing elderly population are anticipated to drive demand for these devices significantly. The success of drainage devices in reducing IOP, especially in patients who have not responded well to conventional treatments, is projected to enhance their adoption in clinical settings.

Glaucoma Surgery Devices Market, By Surgery Type

• Conventional Glaucoma Surgeries
• Minimally Invasive Glaucoma Surgeries

Based on Surgery Type, the global Glaucoma Surgery Devices Market is divided into Conventional Glaucoma Surgeries and Minimally Invasive Glaucoma Surgeries. The segment of conventional glaucoma surgeries is expected to hold the largest share of the glaucoma surgery devices market. This segment includes established procedures such as trabeculectomy and tube shunt surgeries, which have been widely utilized for many years. A high prevalence of advanced glaucoma cases requiring surgical intervention is anticipated to drive demand in this category. The effectiveness of these traditional surgical methods in significantly lowering intraocular pressure is projected to enhance their continued use in clinical practice.

Glaucoma Surgery Devices Market, By End-Users

• Eye Hospitals And Ophthalmology Clinics
• Ambulatory Surgical Centers
• Outpatient Surgical Centers

Based on End-Users, the market is segmented into Eye Hospitals And Ophthalmology Clinics, Ambulatory Surgical Centers, and Outpatient Surgical Centers. Eye hospitals and ophthalmology clinics are expected to hold the largest share of the glaucoma surgery devices market due to the increasing demand for specialized eye care services. These facilities are anticipated to benefit from a growing prevalence of glaucoma and a rising awareness among the population regarding eye health. The availability of advanced surgical technologies within these settings is likely to enhance treatment outcomes, thereby attracting more patients seeking glaucoma management.

Glaucoma Surgery Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the global glaucoma surgery devices market is classified into North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific region is expected to be a rapidly growing market for glaucoma surgery devices, primarily due to the rising prevalence of glaucoma among aging populations. Countries such as China and India are projected to witness significant increases in demand, driven by a combination of population growth and urbanization. Investments in healthcare infrastructure are likely to support the market's expansion in these countries.

Key Players

The "Global Glaucoma Surgery Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Carl Zeiss Meditec AG, Abbott Laboratories, Iridex Corporation, Alcon, Inc., Glaukos Corporation, ASICO, Katalyst Surgical, Nidek Co., Ltd., Ziemer Ophthalmic Systems AG, and Lumenis Ltd. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Glaucoma Surgery Devices Market Recent Developments
• In July 2022, a strategic partnership for the treatment of glaucoma was announced by iSTAR Medical and AbbVie. This collaboration afforded AbbVie the opportunity to significantly diversify its line of eye care products and offer glaucoma patients more treatment options.
• In November 2021, SMART Solutions by Alcon, a digital platform specifically created for ophthalmology, was demonstrated at the American Academy of Ophthalmology (AAO) 2021 annual conference by Alcon, the world leader in eye care committed to supporting people in seeing brilliantly. This innovative platform is reinforced by Alcon's leadership in the clinic-to-operating room, integration with image-guided technologies, and cloud-based planning

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL GLAUCOMA SURGERY DEVICES MARKET

• 1.1 Introduction of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL GLAUCOMA SURGERY DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Glaucoma Drainage Devices
• 5.3 Glaucoma Laser Devices
• 5.4 Implants & Stents

6 GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE

• 6.1 Overview
• 6.2 Minimally Invasive Glaucoma Surgeries
• 6.3 Conventional Glaucoma Surgeries

7 GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY END-USERS

• 7.1 Overview
• 7.2 Eye Hospitals & Ophthalmology Clinics
• 7.3 Ambulatory Surgical Centers
• 7.4 Outpatient Surgical Centers

8 GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL GLAUCOMA SURGERY DEVICES MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Carl Zeiss Meditec AG
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Abbott Laboratories
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Iridex Corporation
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Alcon, Inc.
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Glaukos Corporation
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 ASICO
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Katalyst Surgical
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Ziemer Ophthalmic Systems AG
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Lumenis Ltd.
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments

11 Appendix

• 11.1 Related Research"